Stock Detail
VERA BRADLEY INC
Sector: Drugs
Latest Quote @ Sat May 5 12:23:17 (15 min delayed)
| N/A |
N/A |
$23.59 |
+0.18 |
0.77% |
|
Last Day's Data
| $23.59 |
$24.35 |
$0.18 |
0.77% |
0.00 |
$23.41 |
| $23.68 |
$23.55 |
338,713.00 |
957.81M |
312,820.00 |
13.89 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 24.63 |
24.11 |
23.83 |
23.31 |
23.03 |
Stock Profile
Viragen, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of technologies and products used for the treatment of infectious diseases and cancers in humans worldwide. Its products primarily include Multiferon, leukocyte derived multisubtype interferon alpha, used for the treatment of various viral diseases and cancer indications; VG101, an antibody to the GD3 antigen, which is expressed on malignant melanoma tumors, thereby preventing the body's natural immune system from stopping cancer cell growth and proliferation; and VG102, an antibody to the CD55 antigen, which is expressed on various cancerous tumors and which prevents the body's natural immune system from killing cancer cells. The company also involves in developing Avian Transgenics technology to develop and use transgenic chickens to produce therapeutic proteins and antibodies for human use in the whites of eggs. Viragen was founded in 1979 and is headquartered in Plantation, Florida.
